Puzzo, F., Colella, P., Biferi, M. G., Bali, D., Paulk, N. K., Vidal, P., … Mingozzi, F. (2017). Whole-body correction of Pompe disease by AAV liver-mediated gene transfer of engineered secretable GAA transgenes. In HUMAN GENE THERAPY (Vol. 28, pp. A12–A12). Berlin, GERMANY: MARY ANN LIEBERT, INC.

Puzzo, F., P. Colella, M. G. Biferi, D. Bali, N. K. Paulk, P. Vidal, F. Collaud, et al. “Whole-body correction of Pompe disease by AAV liver-mediated gene transfer of engineered secretable GAA transgenes.” In HUMAN GENE THERAPY, 28:A12–A12. MARY ANN LIEBERT, INC, 2017.

Puzzo F, Colella P, Biferi MG, Bali D, Paulk NK, Vidal P, et al. Whole-body correction of Pompe disease by AAV liver-mediated gene transfer of engineered secretable GAA transgenes. In: HUMAN GENE THERAPY. MARY ANN LIEBERT, INC; 2017. p. A12–A12.

Puzzo, F., et al. “Whole-body correction of Pompe disease by AAV liver-mediated gene transfer of engineered secretable GAA transgenes.” HUMAN GENE THERAPY, vol. 28, no. 12, MARY ANN LIEBERT, INC, 2017, pp. A12–A12.

Puzzo F, Colella P, Biferi MG, Bali D, Paulk NK, Vidal P, Collaud F, Simon-Sola M, Charles S, Hardet R, Leborgne C, Meliani A, Cohen-Tannoudji M, Astord S, Gjata B, Sellier P, van Wittenberghe L, Vignaud A, Boisgerault F, Barkats M, Laforet P, Kay MA, Koeberl DD, Ronzitti G, Mingozzi F. Whole-body correction of Pompe disease by AAV liver-mediated gene transfer of engineered secretable GAA transgenes. HUMAN GENE THERAPY. MARY ANN LIEBERT, INC; 2017. p. A12–A12.